Among 32 cancer tissues, in 11 cancer types (BLCA, BRCA, head and neck squamous cell carcinoma (HNSC), LIHC, LUAD, MESO, OV, rectal adenocarcinoma (READ), SARC, skin cutaneous melanoma (SKCM), and STAD), the rate of survival was significantly higher among patients whose tumors had high levels of NEAT1 expression compared with those with low NEAT1-expressing tumors ("Good" in “Total” column of Table 1). This evidence concerns the gene NEAT1 and bladder transitional cell carcinoma.